BioWorld - Monday, February 9, 2026

BioWorld Science

March 9, 2020

View Archived Issues

Chimeric BET degrader-antibody conjugate shows improved PK and in vivo antitumor activity

Read More

Health Canada approves phase I study of Cardiol's ultra-pure CBD formulation

Read More

EMILIN3 and INA identified as novel markers of LG-ESS using comparative proteomics

Read More

11beta-HSD1 as a new marker of response to IC blockade therapy in NSCLC

Read More

Mutations in PIK3-ATK-MTOR pathway linked to poor prognosis in oligodendrogliomas

Read More

Rapamycin, telomeres have unexpectedly complex relationship

Read More

Serine improves memory in Alzheimer's mouse model

Read More

From junk to noncoding to coding

Read More

Adipophilin tied to poor prognosis in malignant melanoma

Read More

Asceneuron patents new OGA inhibitors

Read More

Shanghai Allist Pharmaceutical discloses EGFR mutant inhibitors

Read More

Nanjing TransThera Biosciences identifies TAM family kinases inhibitors

Read More

CytoDyn submits IND application to study leronlimab for COVID-19 respiratory complications

Read More

Algernon makes ifenprodil available for compassionate use for coronavirus

Read More

ALRN-6924 upregulates P21 expression in AML/MDS patients

Read More

FDA approves Isturisa for Cushing's disease

Read More

Compugen releases new data from phase I study of COM-701 in advanced solid tumors

Read More

Netherlands Cancer Institute plans phase I/Ib study of RMC-4630 with ERK inhibitor

Read More

Ascentage cleared to begin new trials of APG-2575 in U.S. and China

Read More